Is. J.Jill Facing Existential Threat With Other Womens Retailers?

Photo of Chris Lange
By Chris Lange Updated Published
Is. J.Jill Facing Existential Threat With Other Womens Retailers?

© filo / Getty Images

J.Jill Inc. (NYSE: JILL) shares were absolutely crushed on Thursday morning after the company reported its fiscal first-quarter financial results. The company said that it had $0.10 in earnings per share (EPS) and $176.5 million in revenue, which compared with consensus estimates of $0.17 in EPS and revenue of $180.04 million. The same period of last year reportedly had EPS of $0.29 on $181.54 million in revenue.

During the most recent quarter, total comparable sales decreased 3.3%. Direct to consumer net sales represented 41.9% of total net sales, compared to 40.5% in the first quarter of fiscal 2018.

Management said that it would take immediate actions to clear excess inventory and position the business for improved results in the second half of the year.

While J.Jill is still profitable, slowing sales and trends may make investors wonder about the future. It also says something that about 34.5% of J.Jill’s float is sold short.

[nativounit]

Looking ahead to the fiscal second quarter, the company expects to see a net loss per share of $0.08 to $0.10 and comparable sales decreasing in the range of 1% to 3%. Consensus estimates call for $0.21 in EPS and $180.19 million in revenue for the quarter.

Linda Heasley, president and CEO of J.Jill, commented:

We are early in the process of executing against our updated long-term strategies, and our new leadership team across key areas of the business is now in place and will begin to have greater impacts on the business. We are incorporating key learnings from the first quarter and will continue to assess investments in technology and process improvements to ensure the team has the tools to satisfy our core customers and capture the opportunities we see ahead for the J.Jill brand.

Shares of J.Jill traded down about 54% at $1.66 Thursday morning, in a new 52-week range of $1.58 to $8.08. The consensus price target is $7.43.

[recirclink id=550498]
[wallst_email_signup]

Contact [email protected] for any questions or corrections.

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics. Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications. A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

META Vol: 40,760,422
KMX Vol: 2,288,021
WY Vol: 6,523,553
SBAC Vol: 1,443,801
NVDA Vol: 148,249,982

Top Losing Stocks

MRNA Vol: 9,176,778
CTRA Vol: 73,319,495
CRWD Vol: 9,269,567
DDOG Vol: 5,135,556
EPAM Vol: 1,164,561